Abstract:IMPORTANCE: Endovascular therapy (ET) is typically not considered for patients with large baseline ischemic cores (irreversibly injured tissue). Computed tomographic perfusion (CTP) imaging may identify a subset of patients with large ischemic cores who remain at risk for significant infarct expansion and thus could still benefit from reperfusion to reduce their degree of disability.OBJECTIVE: To compare the outcomes of patients with large baseline ischemic cores on CTP undergoing ET with the outcomes of matched controls who had medical care alone.DESIGN, SETTING, AND PARTICIPANTS: A matched case-control study of patients with proximal occlusion after stroke (intracranial internal carotid artery and/or middle cerebral artery M1 and/or M2) on computed tomographic angiography and baseline ischemic core greater than 50 mL on CTP at a tertiary care center from May 1, 2011, through October 31, 2015. Patients receiving ET and controls receiving medical treatment alone were matched for age, baseline ischemic core volume on CTP, and glucose levels. Baseline characteristics and outcomes were compared.MAIN OUTCOMES AND MEASURES: The primary outcome measure was the shift in the degree of disability among the treatment and control groups as measured by the modified Rankin Scale (mRS) (with scores ranging from 0 [fully independent] to 6 [dead]) at 90 days.RESULTS: Fifty-six patients were matched across 2 equally distributed groups (mean [SD] age, 62.25 [13.92] years for cases and 58.32 [14.79] years for controls; male, 13 cases [46%] and 14 controls [50%]). Endovascular therapy was significantly associated with a favorable shift in the overall distribution of 90-day mRS scores (odds ratio, 2.56; 95% CI, 2.50-8.47; P = .04), higher rates of independent outcomes (90-day mRS scores of 0-2, 25% vs 0%; P = .04), and smaller final infarct volumes (mean [SD], 87 [77] vs 242 [120] mL; P < .001). One control (4%) and 2 treatment patients (7%) developed a parenchymal hematoma type 2 (P > .99). The rates of hemicraniectomy (2 [7%] vs 6 [21%]; P = .10) and 90-day mortality (7 [29%] vs 11 [48%]; P = .75) were numerically lower in the intervention arm. Sensitivity analysis for patients with a baseline ischemic core greater than 70 mL (12 pairs) revealed a significant reduction in final infarct volumes (mean [SD], 110 [65] vs 319 [147] mL; P < .001) but only a nonsignificant improvement in the overall distribution of mRS scores favoring the treatment group (P = .18). All 11 patients older than 75 years had poor outcomes (mRS score >3) at 90 days.CONCLUSIONS AND RELEVANCE: In properly selected patients, ET appears to benefit patients with large core and large mismatch profiles. Future prospective studies are warranted.

Unsuccessful Recanalization versus Medical Management of Patients with Large Ischemic Core

Endovascular recanalization for chronic symptomatic intracranial vertebral artery total occlusion.

Exploring the Relationship Between Ischemic Core Volume and Clinical Outcomes after Thrombectomy or Thrombolysis

Patients with Ischemic Core ≥70 Ml Within 6 H of Symptom Onset May Still Benefit from Endovascular Treatment

Endovascular thrombectomy versus medical management on outcomes with infarct volumes more than 70 mL

Endovascular Therapy and Outcomes Among Patients With Very Large Ischemic Core Stroke

Endovascular Therapy versus Medical Management for Acute Ischemic Stroke with Large Infarct Core: systematic review and meta-analysis of randomized controlled trials

Endovascular Treatment for Minor Acute Ischemic Strokes with Large Vessel Occlusion

Endovascular treatment versus standard medical treatment in patients with established large infarct: a cohort study

Abstract 1: The Very Core Limit Of Endovascular Therapy For Acute Stroke With A Large Ischemic Region

Association of Endovascular Thrombectomy with Functional Outcome in Patients with Acute Stroke with a Large Ischemic Core.

Characteristics and prognostic impact of unsuccessful recanalization after endovascular therapy for acute ischemic stroke

Effect of occlusion site on the effectiveness and safety of endovascular thrombectomy for large ischemic cores: A cohort study

Endovascular Thrombectomy for Large Ischemic Stroke Across Ischemic Injury and Penumbra Profiles

Abstract TP189: Outcome Differences Between Endovascular Thrombectomy and Medical Management Based on Underlying Stroke Etiology: A Secondary Analysis of SELECT2 Trial

Endovascular thrombectomy versus medical management for patients with large vessel stroke and infective endocarditis

Endovascular Treatment for Patients With Acute Stroke Who Have a Large Ischemic Core and Large Mismatch Imaging Profile

Predictors of recurrence and complications for the endovascular treatment of unruptured middle cerebral artery aneurysm: A high-volume center experience over 12 years

Alberta Stroke Program Early Computed Tomography Score, Infarct Core Volume, and Endovascular Therapy Outcomes in Patients With Large Infarct

Exploring Ischemic Core Growth Rate and Endovascular Therapy Benefit in Large Core Patients

A comparison of endovascular therapy and medical management in patients with large vessel occlusion mild stroke treated between 2015 and 2023: a systematic review and meta-analysis